In a clinical trial, 17 out of 863 patients taking a prescription drug daily complained of flulike symptoms. Suppose that it is known that 1.6% of patients taking competing drugs complain of flulike symptoms. Is there sufficient evidence to conclude that more than 1.6% of this drug's users experience flulike symptoms as a side effect at the α=0.1 level of significance?
Because np (01−p0) =__?__
▼
>
=
<
≠
10, the sample size is
▼
less than
greater than
5% of the population size, and the sample
▼
is given to not be random,
is given to be random,
cannot be reasonably assumed to be random,
can be reasonably assumed to be random,
the requirements for testing the hypothesis
▼
are
are not
satisfied.
(Round to one decimal place as needed.)
p0 = 1.6% = 0.016
np0 (1-p0) = 863 * 0.016 * (1- 0.016) = 13.587
Because, np0 (1-p0) > 10
the sample size is less than 5% of the population size, and the sample
can be reasonably assumed to be random
the requirements for testing the hypothesis
are satisfied.
H0: p0 = 0.016
H1: p0 > 0.016
Standard error of proportion = = 0.00427
Sample proportion, p = 17/863 = 0.0197
Test statistic, z = (p - p0) / Std error
= (0.0197 - 0.016) / 0.00427
= 0.8665
P-value = P(z > 0.8665) = 0.1931
Since, p-value is greater than 0.01 significance level, we fail to reject null hypothesis H0 and there is no sufficient evidence to conclude that more than 1.6% of this drug's users experience flulike symptoms as a side effect
Get Answers For Free
Most questions answered within 1 hours.